Non-viral Vectors in Gene Therapy: Recent Development, Challenges, and Prospects

Area of Science:

• Biotechnology
• Gene Therapy Delivery Systems

Background:

• Gene therapy is advancing rapidly, but relies heavily on viral vectors that are difficult to produce commercially.
• Non-viral vectors (polymers, lipids, inorganic particles) are being explored as safer alternatives with lower cytotoxicity and immunogenicity.

Purpose of the Study:

• This review examines recent progress in non-viral vector research for gene delivery.
• It highlights formulation advancements, current challenges, and future directions in the field.

Main Methods:

• Literature review of recent advancements in non-viral vector technology.
• Analysis of formulation strategies and their impact on gene delivery.
• Discussion of challenges and future research perspectives.

Main Results:

• Non-viral vectors show potential due to reduced toxicity and immunogenicity compared to viral vectors.
• Key challenges remain, including low gene transfer efficiency, specificity, and long-term gene expression.
• Formulation optimization is crucial for improving non-viral vector performance.

Conclusions:

• Non-viral vectors represent a critical area of development for cost-effective and safer gene therapy.
• Addressing current limitations in efficiency, specificity, and safety is essential for clinical translation.
• Continued research into novel formulations and delivery strategies is vital for realizing the full potential of non-viral gene delivery.